InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.23
(
0.77%
)
US TECH 100
19,409.60
(
1.26%
)
Dow Jones
38,778.10
(
0.49%
)
Brent Oil
83.60
(
-0.36%
)
Bitcoin
65,544.35
(
-1.42%
)
Post# of 26138
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Al100

Send PM Follow Ignore
Followers 15
Posts 1656
Boards Moderated 0
Alias Born 06/01/2012

Al100

Re: None

Monday, 06/04/2012 11:08:47 AM

Monday, June 04, 2012 11:08:47 AM

Post# of 26138
Checking the company website and reading past 4 news releases for conferences, they have never mentioned in any of them what subjects Simes was going to talk about. For the Jefferies Conference, they have added this;




Mr. Simes will provide an overview of BioSante, as well as an update on the LibiGel® (testosterone gel) Phase III clinical development program, and a review of published results using BioSante´s GVAX Cancer Immunotherapies in combination with ipilimumab (Ipi; Yervoy; BMS).
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up